Skin cancer treatment
AssigneeImcomet B.V.
InventorAlexandre Charles Roger Motta
Life of this patent
Estimating the term…
Abstract
The present invention relates to the fields of medicine and cancer, more particularly to the field of skin cancer (e.g. melanoma and non-melanoma cancers) and skin cancer treatment. Provided are methods for treating skin cancer using microneedle devices for the removal of an amount of interstitial fluid or tumor interstitial fluid from a skin tumor. Also provided are therapeutic compounds for use in the treatment of skin cancer, wherein the treatment comprises removal of an amount of interstitial fluid or tumor interstitial fluid from a skin tumor.
Claims12
A method for treating a subject with a skin tumor said method comprising the step of removing an amount of interstitial fluid from said skin tumor.
A therapeutic agent for use in a method for treating a subject with a skin tumor, wherein the therapeutic agent is selected from the group of an immune checkpoint inhibitor, an oncolytic virus, an engineered T-cell, a (cancer) vaccine, a BRAF inhibitor, a MAPK inhibitor, a MEK inhibitor, and a chemotherapeutic agent, and wherein the treatment comprises removing interstitial fluid from the skin tumor.
An extracellular fluid and/or intracellular fluid obtained from a skin tumor for use in the treatment of skin cancer, wherein the skin cancer is treated by removal of the interstitial fluid from the skin tumor.
Dependencies are inferred from the claim text.